Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer
AUAUniversity31 Mar 2017

Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

The goal of this knowledge-based activity is to improve clinicians' understanding of current immunotherapeutic agents for the treatment of bladder cancer and to increase their ability to improve patient outcomes and the management of adverse events. Educational grants provided by the following corportations: AstraZeneca, Bristol-Myers Squibb, Genentech, Merck

Episoder(425)

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-strid-de-norske-borgerkrigene
treningspodden
rss-sunn-okonomi
foreldreradet
jakt-og-fiskepodden
takk-og-lov-med-anine-kierulf
merry-quizmas
sinnsyn
smart-forklart
lederskap-nhhs-podkast-om-ledelse
rss-kunsten-a-leve
hverdagspsyken
gravid-uke-for-uke
level-up-med-anniken-binz
rss-kull
fryktlos
hagespiren-podcast